Reck, M; Ciuleanu, TE; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Reyes, F; Souquet, PJ; De Marchiy, P; Martin, C; Perol, M; Scherpereel, A; Lu, S; Paz-Ares, L; Carbone, DP; Memaj, A; Marimuthu, S; Zhang, X; Tran, P; John, T – 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02 | 0 Comentarios